These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29356833)

  • 1. [Severe lymphopenia in a patient with Crohn's disease].
    Monasterio C; Kreisel W; Hasselblatt P
    Internist (Berl); 2018 Aug; 59(8):857-860. PubMed ID: 29356833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adalimumab reversed a severe lymphopenia in a patient with Crohn's disease.
    Taxonera C; Mendoza JL; Ortega L; Pérez MI; Díaz-Rubio M
    J Crohns Colitis; 2012 May; 6(4):488-91. PubMed ID: 22398051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor necrosis factor agents reduce corticosteroid use compared with azathioprine in patients with Crohn's disease.
    Kane SV; Jaganathan S; Bedenbaugh AV; Palmer L; Schwartz DA
    Curr Med Res Opin; 2014 Sep; 30(9):1821-6. PubMed ID: 24884302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concerns and Side Effects of Azathioprine During Adalimumab Induction and Maintenance Therapy for Japanese Patients With Crohn's Disease: A Subanalysis of a Prospective Randomised Clinical Trial [DIAMOND Study].
    Hisamatsu T; Matsumoto T; Watanabe K; Nakase H; Motoya S; Yoshimura N; Ishida T; Kato S; Nakagawa T; Esaki M; Nagahori M; Matsui T; Naito Y; Kanai T; Suzuki Y; Nojima M; Watanabe M; Hibi T;
    J Crohns Colitis; 2019 Sep; 13(9):1097-1104. PubMed ID: 30753377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated cutaneous herpes simplex infection in a patient with Crohn's disease under azathioprine and steroids: First case report and literature review.
    Santos-Antunes J; Abreu C; Magro F; Coelho R; Vilas-Boas F; Andrade P; Lopes S; Macedo G
    J Crohns Colitis; 2014 Apr; 8(4):326-30. PubMed ID: 24257435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adalimumab and Azathioprine Combination Therapy for Crohn's Disease: A Shining Diamond?
    Fiorino G; Danese S
    J Crohns Colitis; 2016 Nov; 10(11):1257-1258. PubMed ID: 27389085
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy.
    Ferrer Bradley I; Maroto Arce N; Mora Escrig M; Hinojosa Del Val J
    Gastroenterol Hepatol; 2019; 42(6):387-388. PubMed ID: 30042000
    [No Abstract]   [Full Text] [Related]  

  • 8. Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized Trial.
    Matsumoto T; Motoya S; Watanabe K; Hisamatsu T; Nakase H; Yoshimura N; Ishida T; Kato S; Nakagawa T; Esaki M; Nagahori M; Matsui T; Naito Y; Kanai T; Suzuki Y; Nojima M; Watanabe M; Hibi T;
    J Crohns Colitis; 2016 Nov; 10(11):1259-1266. PubMed ID: 27566367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine discontinuation earlier than 6 months in Crohn's disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation.
    Viazis N; Koukouratos T; Anastasiou J; Giakoumis M; Triantos C; Tsolias C; Theocharis G; Karamanolis DG
    Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):436-41. PubMed ID: 25874518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's sarcoma developing in a HIV-negative Crohn's disease patient shortly after azathioprine and corticosteroid treatment.
    Kilincalp S; Akıncı H; Hamamci M; Coşkun Y; Yüksel I
    J Crohns Colitis; 2014 Jun; 8(6):558-9. PubMed ID: 24291020
    [No Abstract]   [Full Text] [Related]  

  • 11. Vulval Crohn's disease: a clinical study of 22 patients.
    Laftah Z; Bailey C; Zaheri S; Setterfield J; Fuller LC; Lewis F
    J Crohns Colitis; 2015 Apr; 9(4):318-25. PubMed ID: 25687208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab, azathioprine, or combination therapy for Crohn's disease.
    Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens G; Diamond RH; Broussard DL; Tang KL; van der Woude CJ; Rutgeerts P;
    N Engl J Med; 2010 Apr; 362(15):1383-95. PubMed ID: 20393175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course.
    Harris RE; Aloi M; de Ridder L; Croft NM; Koletzko S; Levine A; Turner D; Veereman G; Neyt M; Bigot L; Ruemmele FM; Russell RK;
    BMJ Open; 2020 Jul; 10(7):e034892. PubMed ID: 32611737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary cryptococcosis in a patient with Crohn's disease treated with prednisone, azathioprine and adalimumab: exposure to chicken manure as a source of contamination.
    Fraison JB; Guilpain P; Schiffmann A; Veyrac M; Le Moing V; Rispail P; Le Quellec A
    J Crohns Colitis; 2013 Feb; 7(1):e11-4. PubMed ID: 22647638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hodgkin's lymphoma in a patient with Crohn's disease treated with azathioprine and antibodies anti tumor necrosis factor α].
    Sagüés M; Navarro JT; Ribera JM; Millá F
    Med Clin (Barc); 2012 Apr; 138(8):366-7. PubMed ID: 21752407
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience.
    Peyrin-Biroulet L; Salleron J; Filippi J; Reenaers C; Antunes O; Filipe V; Louis E; Hébuterne X; Roblin X
    J Crohns Colitis; 2016 May; 10(5):516-24. PubMed ID: 26802084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
    Walters TD; Kim MO; Denson LA; Griffiths AM; Dubinsky M; Markowitz J; Baldassano R; Crandall W; Rosh J; Pfefferkorn M; Otley A; Heyman MB; LeLeiko N; Baker S; Guthery SL; Evans J; Ziring D; Kellermayer R; Stephens M; Mack D; Oliva-Hemker M; Patel AS; Kirschner B; Moulton D; Cohen S; Kim S; Liu C; Essers J; Kugathasan S; Hyams JS;
    Gastroenterology; 2014 Feb; 146(2):383-91. PubMed ID: 24162032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Extraintestinal Manifestation of Crohn's Disease Treated Successfully with Adalimumab.
    Shin D; Park BK; Seo J; Won SY; Lee MK; Hong YK; Cho YS
    Korean J Gastroenterol; 2018 Sep; 72(3):141-145. PubMed ID: 30270596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crohn's Disease Activity and Concomitant Immunosuppressants Affect the Risk of Serious and Opportunistic Infections in Patients Treated With Adalimumab.
    Osterman MT; Sandborn WJ; Colombel JF; Peyrin-Biroulet L; Robinson AM; Zhou Q; Lewis JD
    Am J Gastroenterol; 2016 Dec; 111(12):1806-1815. PubMed ID: 27670599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.